RAN BioLinks
- Company typePrivate
- Founded2007
- HeadquartersRichmond Hill, Canada
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
RAN BioLinks firmographics
Firmographics- Name
- RAN BioLinks
- Legal name
- RAN BioLinks Canada
- Website
- https://ranbiolinks.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
RAN BioLinks industry classification
Industry- Product category
- Life Sciences Software
- NAICS
- Software Publishers (51321)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)
Keywords
Where RAN BioLinks is headquartered
LocationHeadquarters
- HQ city
- Richmond Hill
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
RAN BioLinks business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Software Subscription (SaaS): RAN BioLinks operates as a product company selling access to the MAESTRO platform ecosystem. Access to and use of products is governed by separate written agreements, suggesting enterprise subscription licensing. The platform supports both multi-tenant SaaS and dedicated single-tenant deployments.
- Professional Services: Implementation, migration, and validation services are part of the customer engagement model. Training in English and French, validation evidence aligned to GAMP 5, and migration support are mentioned as service components.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
RAN BioLinks product offering
Product offeringCore offering
RAN BioLinks builds and sells the MAESTRO platform, a unified, AI-native, cloud-agnostic software ecosystem for the life sciences industry. The platform integrates clinical trial management, inventory management, electronic content management, biobanking, and bioinformatics into a single multi-tenant SaaS suite sold to pharmaceutical sponsors, CROs, health authorities, academic centers, and biotech companies.
Product overview
RAN BioLinks builds MAESTRO — a unified software ecosystem (operating system) for life sciences. The platform combines traditionally separate clinical research, supply chain, content & compliance, biobanking, and bioinformatics tools into one cohesive product suite. MAESTRO consists of six integrated modules: MAESTRO Clinical Trials (CTMS, eTMF, eISF, QMS), MAESTRO IMS (Inventory Management), MAESTRO ECMS (Content & Compliance), MAESTRO Biobank (Biospecimen Management), Bioinformatics (Engineering & Pipelines), all built on a unified data layer, AI core, and shared audit trail. Each module operates independently but shares a common platform foundation, enabling seamless data flow and unified operations across clinical research, inventory, content, and biobanking domains.
Differentiator
Problem solved
Functional benefit
Brands
- MAESTRO: Unified software ecosystem spanning clinical research (CTMS, eTMF, eISF, QMS), inventory management, enterprise content & compliance, biobanking and bioinformatics
- MAESTRO Clinical Trials
- MAESTRO IMS
- MAESTRO ECMS
- MAESTRO Biobank
- Bioinformatics
Products and services
- MAESTRO Clinical Trials Clinical trial management system (CTMS) for life sciences organizations to plan, run, and oversee studies end-to-end. Targeted at pharmaceutical sponsors, CROs, and academic centers.
- MAESTRO IMS (Inventory Management System) Inventory management module for tracking reagents, supplies, and lab assets within life sciences operations. Used by sponsors, CROs, and research organizations.
- MAESTRO ECMS (Electronic Content Management System) Electronic content management module for regulated documents, supporting controlled authoring, review, and retention workflows aligned with 21 CFR Part 11. Targeted at regulated life sciences organizations.
- MAESTRO Biobank Biobanking management module that handles sample tracking, chain of custody, and biospecimen data for translational research and clinical studies. Used by academic centers, health authorities, and biotech companies.
- MAESTRO Bioinformatics Bioinformatics capability embedded in the MAESTRO platform for analyzing biological data alongside clinical and biobanking workflows. Targeted at research-driven life sciences organizations.
Quantifiable outcome
- 98.6% live operational throughput
- +3 more outcomes
Companies that use RAN BioLinks
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
RAN BioLinks technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability7 records
Feature6 records
RAN BioLinks partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, minor, flagship and supporting.
- DataikucoreStrategic alliance to advance AI-driven clinical research through advanced analytics, machine learning, and scalable healthcare solutions. Combines RAN BioLinks' clinical trials platform with Dataiku's enterprise AI platform.
- Deep Tech CanadaminorParticipated in BioJapan 2025 as part of Deep Tech Canada's life sciences trade mission, connecting Canadian biotech innovation with Japan's life sciences ecosystem.
- European Plotkin Institute for Vaccinology (EPIV)flagshipCollaboration on African-led COVID-19 vaccine study in people living with HIV. RAN BioLinks provides data platform, sample tracking, and study oversight for this groundbreaking vaccine research initiative.
- The Human Immunome ProjectflagshipCollaboration on African-initiated COVID-19 vaccine study in people living with HIV, advancing vaccine research and immunology. The Human Immunome Project brings scientific expertise while RAN BioLinks provides operational platform support.
- MARKENsupportingCollaboration with MARKEN KIT building in Germany for manufacturing standardized participant kits for the AGREE trial in Kenya, ensuring consistent and high-quality delivery of essential materials.
Scale indicators8 records
Recent moves6 records
RAN BioLinks competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Largest pure-play life-sciences cloud platform, offering Veeva Vault CTMS, eTMF, QMS and quality content management — directly overlapping with MAESTRO Clinical Trials and ECMS modules for the same sponsor and CRO buyers.
- MasterControl: Quality and compliance management suite (QMS, document control, validation, training) targeting regulated life sciences — directly comparable to MAESTRO ECMS and the QMS component of MAESTRO Clinical Trials.
- ArisGlobal: LifeSphere platform spans CTMS, regulatory information management, pharmacovigilance and document management — a tightly comparable mid-size direct competitor to MAESTRO's clinical and ECMS modules.
- LabWare: Leading LIMS/ELN provider for pharmaceutical and biobanking laboratories; MAESTRO Biobank and the lab-adjacent workflows in MAESTRO compete head-to-head with LabWare's sample tracking and chain-of-custody capabilities.
- Medidata Solutions (Dassault Systèmes): Industry-standard clinical trial platform (Rave EDC, CTMS, RTSM, eCOA) used by most large sponsors — the dominant head-to-head competitor for MAESTRO Clinical Trials in pharma and biotech accounts.
Emerging players
- Dotmatics: Unified scientific informatics platform (LIMS, ELN, inventory, BI) for biotech and pharma R&D — emerging alternative for the same Biotech & Diagnostics buyer segment as MAESTRO's bioinformatics and IMS modules.
- Castor: Cloud-native EDC and ePRO platform with a self-serve / PLG motion popular with academic sponsors and investigator-initiated studies — competes for the same academic and biotech segment that MAESTRO Clinical Trials targets.
Broad incumbents
- IQVIA: Largest CRO with a technology arm (E360, OCE, Medidata-adjacent workflows) — competes not only on software but on bundled services, giving sponsors a procurement alternative that RAN BioLinks' software-only model cannot match.
- BIOVIA (Dassault Systèmes): Scientific informatics suite covering ELN, LIMS, inventory and quality — overlaps with MAESTRO IMS, ECMS and Bioinformatics as part of Dassault's broader 3DEXPERIENCE platform sold to large pharma.
- Oracle Health Sciences (Clinical One): Oracle Clinical One and the legacy Oracle Health Sciences suite cover EDC, CTMS and safety within Oracle's much larger enterprise software portfolio — a broad incumbent that bundles life-sciences modules into wider CIO deals.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
RAN BioLinks social profiles
Digital presenceRAN BioLinks compliance and trust
Trust signalCompliance10 records
RAN BioLinks financial estimates
Financial estimateRevenue estimate
Valuation estimate
RAN BioLinks leadership team
Management profileNumber of profiles
Profiles3 records
RAN BioLinks funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RAN BioLinks M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RAN BioLinks
What does RAN BioLinks do?
RAN BioLinks builds and sells the MAESTRO platform, a unified, AI-native, cloud-agnostic software ecosystem for the life sciences industry. The platform integrates clinical trial management, inventory management, electronic content management, biobanking, and bioinformatics into a single multi-tenant SaaS suite sold to pharmaceutical sponsors, CROs, health authorities, academic centers, and biotech companies.
Is RAN BioLinks a public or private company?
RAN BioLinks is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RAN BioLinks founded?
RAN BioLinks was founded in 2007. It employs 11 to 50 people.
Where is RAN BioLinks based?
RAN BioLinks is headquartered in Richmond Hill, Canada, in the North America region.
How does RAN BioLinks make money?
Two revenue lines are on record. Software Subscription (SaaS) is the primary driver. The others are professional Services.
Who are RAN BioLinks's main competitors?
Direct peers on record are Veeva Systems, MasterControl, ArisGlobal, LabWare and Medidata Solutions (Dassault Systèmes). Emerging players are Dotmatics and Castor. Broad incumbents are IQVIA, BIOVIA (Dassault Systèmes) and Oracle Health Sciences (Clinical One).
Does RAN BioLinks have an API?
Yes. MAESTRO provides a versioned REST API v1 with token authentication. Pre-built connectors and structured exports enable interoperability with external systems. Webhooks and events support automation triggers for BI and reporting exports in PDF, Excel, and CSV formats.
What industry is RAN BioLinks in?
RAN BioLinks's product category is Life Sciences Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAJAL, Regulatory Information Management (RIM) & Submission Publishing Software. Its NAICS code is 51321 and its SIC code is 8731.